advertisement
11.3.3 Apraclonidine, brimonidine (7)
Showing records 1 to 7
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine11713 Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States
Camras CB; Sheu WP; United States Latanoprost-Brimonidine Study Group
Journal of Glaucoma 2005; 14: 161-167
11923 Alphagan allergy may increase the propensity for multiple eye-drop allergy
Osborne SA; Montgomery DMI; Morris D; McKay IC
Eye 2005; 19: 129-137
12096 Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma
Ozturk F; Ermis SS; Inan UU; Asagidag A; Yaman S
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 68-74
11977 Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
Sharpe ED; Henry CJ; Mundorf TK; Day DG; Stewart JA; Jenkins JN; Stewart WC
Eye 2005; 19: 35-40
12013 Anterior uveitis and topical brimonidine: a case report
Velasque L; Ducousso F; Pernod L; Vignal R; Deral V
Journal Français d'Ophtalmologie 2004; 27: 1150-1152
12043 Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy
Yuen NS; Cheung P; Hui SP
Japanese Journal of Ophthalmology 2005; 49: 89-92
11667 Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination
Akman A; Cetinkaya A; Akova YA; Ertan A
Eye 2005; 19: 145-151
